| Literature DB >> 28362580 |
John A Pearce, Alicia A Petryk, P Jack Hoopes.
Abstract
Iron oxide nanoparticles are currently under investigation as heating agents for hyperthermic treatment of tumors. Major determinants of effective heating include the biodistribution and minimum iron oxide loading required to achieve adequate heating at practically achievable magnetic field strengths. These inter-related criteria ultimately determine the practicality of this approach to tumor treatment. Further, in our experience the currently used treatment assessment criterion for hyperthermia treatment-cumulative equivalent minutes at 43 °C, CEM43 -provides an inadequate description of the expected treatment effectiveness.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28362580 PMCID: PMC5753587 DOI: 10.1109/TBME.2017.2666738
Source DB: PubMed Journal: IEEE Trans Biomed Eng ISSN: 0018-9294 Impact factor: 4.538